Kathleen P. Rubinstein

Healthcare Policy Analyst

Houston
T 713.276.1650  |  F 713.751.1717

Kathleen P. Rubinstein is a policy analyst who partners with the Healthcare Industry and Public Policy Teams on developing and implementing strategies for achieving client policy goals and resolving their regulatory concerns. Her professional focus centers on matters involving healthcare policy including regulation under the Medicare and Medicaid programs and implementation of the Affordable Care Act.

Kathleen writes extensively on healthcare industry issues and frequently collaborates with the Healthcare Industry and Public Policy Teams on articles and presentations of topical interest. She is the Editor of the BakerHostetler Health Law Update newsletter and blog. A long time instructor at the University of Houston, Kathleen teaches a graduate seminar on healthcare policy for students of public administration, political science and the law.

Select Experience

  • Works collaboratively on developing policy recommendations and legislative proposals; formulating strategic and tactical work plans and crafting communications strategies.
  • Plans and directs the work of stakeholder advisory groups in formulating solutions to complex policy problems.
More »

Experience

  • Works collaboratively on developing policy recommendations and legislative proposals; formulating strategic and tactical work plans and crafting communications strategies.
  • Plans and directs the work of stakeholder advisory groups in formulating solutions to complex policy problems.
  • Engages in research and analysis of existing and emerging policy topics; serves as an information resource on healthcare industry issues, developments and trends. 
  • Monitors, analyzes and assesses the impact of federal and state actions, legislation and rulemaking and emerging initiatives and proposals.
  • Participates in governmental policy and regulatory interactions at state and federal levels; prepares and manages government filings and submissions.

Recognitions

  • Recognition Award, University of Houston Masters of Public Administration Program 
  • List of Outstanding Graduates, National Association of Schools Public Affairs and Administration

Memberships

  • American Hospital Association
  • American Health Lawyers Association
  • University of Houston MPA Program Alumni Network

Services

Industries

Emerging Issues

Admissions

  • [Not an Attorney]

Education

  • M.A., Public Administration, concentration in Health Policy Studies, University of Houston, 1996
  • B.A., Our Lady of the Lake University, 1992, with honors

Blog

In The Blogs

Previous Next
Health Law Update
Don’t Pop the Cork Just Yet—Growing Criticism of Massachusetts AG’s Settlement with Partners Healthcare Just Might Send the Parties Back to the Drawing Board
July 23, 2014
After touting a proposed settlement with Partners HealthCare (Partners) that supposedly would “fundamentally alter [Partners’] negotiating power for 10 years and control health costs across [Partners’] entire network,” Massachusetts...
Read More ->
Health Law Update
The Orphan Drug Wars: HHS Interpretive Rule Clarifies Orphan Drug Exclusion
July 22, 2014
On July 21, 2014, the U.S. Department of Health and Human Services (HHS) released an “Interpretive Rule” in response to a recent U.S. District Court decision that vacated the July 23, 2013, orphan drug rule on the grounds that HHS lacked...
Read More ->
Health Law Update
Buckle Up—Unwinding Phoebe Putney’s Acquisition of Palmyra Down in Georgia May End Up Being Back on the Table
July 21, 2014
Almost one year ago, Federal Trade Commission (FTC) agreed to settle its antitrust challenge of Phoebe Putney Health System’s (Phoebe Putney) acquisition of Palmyra Medical Center (Palmyra) without requiring divesture or any other remedial...
Read More ->
Health Law Update
Let The Rejoicing Begin, Or Not—Massachusetts AG’s Settlement With Partners Healthcare Is No Harbinger of Things to Come
July 14, 2014
After almost half a dozen years of investigating Partners HealthCare’s (Partners) contracting practices and its proposed acquisitions of two competing hospital systems, Massachusetts Attorney General (AG) Martha Coakley announced a “final...
Read More ->
Health Law Update
Compounded Drugs and Medicare Part B: OIG Report Recommends Payment and Oversight Changes
July 10, 2014
The U.S. Department of Health and Human Services (HHS) Office of the Inspector General (OIG) recently published a report titled “Compounded Drugs Under Medicare Part B: Payment and Oversight” (Report) in which it recommended that the...
Read More ->